| 131Ⅰ治疗甲亢后的继发甲减及替代治疗 |
| |
| 引用本文： | 徐颖,徐晓辉. 131Ⅰ治疗甲亢后的继发甲减及替代治疗[J]. 国际放射医学核医学杂志, 2004, 28(6): 265-266 |
| |
| 作者姓名： | 徐颖 徐晓辉 |
| |
| 作者单位： | 617067,四川省攀枝花市中心医院核医学科;617067,四川省攀枝花市中心医院核医学科 |
| |
| 摘 要： | 继发性甲状腺功能减退症(甲减)是131Ⅰ治疗甲状腺功能亢进症(甲亢)后最重要的并发症.早发甲减与晚发甲减的发生机制不尽相同,有待进一步研究.甲减替代治疗是用动物甲状腺提取物还是用L-T3和L-T4复合制剂,目前尚无肯定回答.
|
| 关 键 词： | 甲状腺功能减退症 碘放射性同位素 放射治疗 替代治疗 |
| 文章编号： | 1001-098X(2004)06-0265-02 |
| 修稿时间： | 2004-04-13 |
The secondary hypothyroidism after radioiodine therapy and the replacement treatment |
| |
| XU Ying,XU Xiao-hui. The secondary hypothyroidism after radioiodine therapy and the replacement treatment[J]. International Journal of Radiation Medicine and Nuclear Medicine, 2004, 28(6): 265-266 |
| |
| Authors: | XU Ying XU Xiao-hui |
| |
| Abstract: | The secondary hypothyroidism is the most important intercurrent disease after radioiodine therapy. The early hypothyroidism and the late hypothyroidism are incompletely different in pathogenesis. It needs researching further. There has not yet been an affirmable answer to choose the distillates from animal hypothyroid extract or complex preparation of levo-thyroxine in replacement treatment. |
| |
| Keywords: | secondary hypothyroidism iodine radiosotopes radiotherapy replacement treatment |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
